Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prokidney (PROK) Return on Sales (2022 - 2025)

Prokidney (PROK) has disclosed Return on Sales for 4 consecutive years, with 162.59% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales fell 4550559.0% to 162.59% in Q3 2025 year-over-year; TTM through Sep 2025 was 209.06%, a 4555206.0% decrease, with the full-year FY2024 number at 2149.14%, changed N/A from a year prior.
  • Return on Sales was 162.59% for Q3 2025 at Prokidney, up from 163.43% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 45343.0% in Q3 2024 to a low of 615.54% in Q4 2024.
  • A 4-year average of 10080.15% and a median of 6311.0% in 2023 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: skyrocketed 2480400bps in 2024, then plummeted -4550559bps in 2025.
  • Prokidney's Return on Sales stood at 12211.5% in 2022, then crashed by -48bps to 6311.0% in 2023, then plummeted by -110bps to 615.54% in 2024, then surged by 74bps to 162.59% in 2025.
  • Per Business Quant, the three most recent readings for PROK's Return on Sales are 162.59% (Q3 2025), 163.43% (Q2 2025), and 162.44% (Q1 2025).